SEC Form 3 · accession 0001140361-16-062416
Bionik Laboratories Corp. · BNKL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jules Marc Fried
Officer — VP - U.S. Operations
Period of report
Apr 21, 2016
Accepted (ET)
Apr 28, 2016 · 3:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001508381
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per shareF1 | holding | — | — | — | 868,647 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $0.95 | holding | — | — | — | Apr 21, 2016 | Jun 2, 2025 | Common Stock, par value $0.001 per share | 3,953 | — | D |
| Employee Stock Option (Right to Buy) | $0.25 | holding | — | — | — | Apr 21, 2016 | Jul 29, 2025 | Common Stock, par value $0.001 per share | 906,077 | — | D |
| Employee Stock Option (Right to Buy) | $1.05 | holding | — | — | — | Apr 21, 2016 | Jun 2, 2025 | Common Stock, par value $0.001 per share | 15,291 | — | D |
| Employee Stock Option (Right to Buy) | $0.95 | holding | — | — | — | Apr 21, 2016 | Jul 29, 2025 | Common Stock, par value $0.001 per share | 671,857 | — | D |
Explanation of responses
- F1173,730 of such shares are held in escrow to satisfy potential indemnity claims under that certain Agreement and Plan of Merger dated March 1, 2016, by and among Bionik Laboratories Corp., Bionik Mergerco Inc., Hermano Igo Krebs and Interactive Motion Technologies, Inc.